Genetic Breakthrough at OHSU
By Allison Frost,
Oregon Public Radio
| 10. 29. 2012
[With CGS's Marcy Darnovsky]
Oregon Health and Science University scientist Shoukhrat Mitalipov and his team have created a viable embryo with the genetic material from three different parents. The goal is to prevent genetic diseases from being passed down.
We spoke to Mitalipov in 2009 after baby rhesus macaque monkeys were born using the same science. Now that human genetic material has been used in a similar way, we'll check back in with the research team and an ethicist to discuss the implications of this scientific breakthrough.
Here's a video that shows how Mitalipov's team removed much of the genetic material from one woman's egg and put it into another:
What questions do you have about the medical or ethical implications of this research?
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
By Shoumita Dasgupta, STAT | 10.03.2025
President Trump and health secretary Robert F. Kennedy Jr. have characterized the rise in autism diagnoses in recent years as an epidemic requiring emergency intervention.
This approach is factually wrong: The broadening definition of autism and the improvement in diagnosis...
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Émile P. Torres, Truthdig | 10.17.2025
The Internet philosopher Eliezer Yudkowsky has been predicting the end of the world for decades. In 1996, he confidently declared that the singularity — the moment at which computers become more “intelligent” than humanity — would happen in 2021, though...